India's Sakar Healthcare jumps on regulatory approvals for cancer drugs
BUZZ-India's Sakar Healthcare jumps on regulatory approvals for cancer drugs ** Shares of Sakar Healthcare SAKA.NS rise 11.3% to 960.6 rupees
** Durgmaker gets regulatory approvals for 14 oncology products across European Union, UK and Canada with seven business partners
** Stock headed towards its best session since May 18
** About 1 mln shares traded, 8x their 30-day moving avg
** YTD, SAKA up ~135%
(Reporting by Anuran Sadhu in Bengaluru)
((Anuran.Sadhu@thomsonreuters.com; +91 8697274436;))
Recent news on Sakar Healthcare
See all newsIndia's Sakar Healthcare jumps on regulatory approvals for cancer drugs
Brief: Sakar Healthcare Gets 14 Oncology Product New Approvals In EU, UK, Canada With 7 Business Partners
Brief: Sakar Healthcare Says Co Added To Manufacturing Of Accord's (UK) Finished Product Imatinib Accord
Australia's Algorae Pharmaceuticals rises on licensing deal with Sakar Healthcare
Brief: Algorae Pharmaceuticals Signs Exclusive License Agreement With Sakar